Analyst: Buy This Penny Stock Before Earnings

Roth Capital's new SRTS price target is lofty

Aug 1, 2018 at 12:03 PM
facebook X logo linkedin

The shares of medical technology concern Sensus Healthcare Inc (NASDAQ:SRTS) are higher today, with help from some bullish analyst attention. Specifically, ahead of the company's turn in the earnings spotlight tomorrow, Aug. 2, Roth Capital launched coverage of SRTS stock with a "buy" rating and $12.50 price target -- a premium of 83% to yesterday's close. At last check, Sensus shares were up 2.4% at $6.97.

SRTS shares have pulled back some since touching a record high of $7.71 in mid-June. However, the stock seems to have found support in the $6.60 area, which acted as a ceiling shortly after Sensus Healthcare's initial public offering (IPO) in mid-2016. Further, this area is roughly double the security's all-time low of $3.38, touched last July.

SRTS stock chart aug 1

SRTS is no stranger to upbeat analyst attention, however, especially considering the shares have added more than 76% in the past year. Currently, all three analysts following the equity deem it worthy of a "buy" rating. Plus, the consensus 12-month price target of $9.75 represents a premium of nearly 40% to the stock's current perch.



How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.